145 related articles for article (PubMed ID: 37962827)
1. Development of a Generic Fetal Physiologically Based Pharmacokinetic Model and Prediction of Human Maternal and Fetal Organ Concentrations of Cefuroxime.
Liu XI; Green DJ; van den Anker J; Ahmadzia HK; Burckart GJ; Dallmann A
Clin Pharmacokinet; 2024 Jan; 63(1):69-78. PubMed ID: 37962827
[TBL] [Abstract][Full Text] [Related]
2. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
[TBL] [Abstract][Full Text] [Related]
4. PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Kidney in Pregnant Subjects and Fetus.
Szeto KX; Le Merdy M; Dupont B; Bolger MB; Lukacova V
AAPS J; 2021 Jun; 23(4):89. PubMed ID: 34169370
[TBL] [Abstract][Full Text] [Related]
5. Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir.
Liu XI; Momper JD; Rakhmanina N; van den Anker JN; Green DJ; Burckart GJ; Best BM; Mirochnick M; Capparelli EV; Dallmann A
J Clin Pharmacol; 2020 Feb; 60(2):240-255. PubMed ID: 31489678
[TBL] [Abstract][Full Text] [Related]
6. Preliminary physiologically based pharmacokinetic modeling of renally cleared drugs in Chinese pregnant women.
Song L; Yu Z; Xu Y; Li X; Liu X; Liu D; Zhou T
Biopharm Drug Dispos; 2020 Jun; 41(6):248-267. PubMed ID: 32520400
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.
Abduljalil K; Pansari A; Ning J; Jamei M
Clin Pharmacokinet; 2022 May; 61(5):725-748. PubMed ID: 35067869
[TBL] [Abstract][Full Text] [Related]
8. A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.
De Sousa Mendes M; Lui G; Zheng Y; Pressiat C; Hirt D; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Urien S; Benaboud S
Clin Pharmacokinet; 2017 May; 56(5):537-550. PubMed ID: 27766562
[TBL] [Abstract][Full Text] [Related]
9. Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus.
Mian P; Allegaert K; Conings S; Annaert P; Tibboel D; Pfister M; van Calsteren K; van den Anker JN; Dallmann A
Clin Pharmacokinet; 2020 Jul; 59(7):911-925. PubMed ID: 32052378
[TBL] [Abstract][Full Text] [Related]
10. Application of PBPK modeling in predicting maternal and fetal pharmacokinetics of levetiracetam during pregnancy.
Chen J; You X; Wu W; Guo G; Lin R; Ke M; Huang P; Lin C
Eur J Pharm Sci; 2023 Feb; 181():106349. PubMed ID: 36496167
[TBL] [Abstract][Full Text] [Related]
11. Development and Verification of a Linked
Patilea-Vrana GI; Unadkat JD
Drug Metab Dispos; 2021 Jul; 49(7):509-520. PubMed ID: 33952608
[TBL] [Abstract][Full Text] [Related]
12. Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19.
Liu XI; Dallmann A; Brooks K; Best BM; Clarke DF; Mirochnick M; van den Anker JN; Capparelli EV; Momper JD
CPT Pharmacometrics Syst Pharmacol; 2023 Feb; 12(2):148-153. PubMed ID: 36479969
[TBL] [Abstract][Full Text] [Related]
13. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics?
Liu XI; Green DJ; van den Anker JN; Rakhmanina NY; Ahmadzia HK; Momper JD; Park K; Burckart GJ; Dallmann A
Front Pediatr; 2021; 9():723006. PubMed ID: 34733804
[No Abstract] [Full Text] [Related]
15. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
Zhang Z; Unadkat JD
Drug Metab Dispos; 2017 Aug; 45(8):939-946. PubMed ID: 28049636
[TBL] [Abstract][Full Text] [Related]
16. Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions.
Hanke N; Gómez-Mantilla JD; Ishiguro N; Stopfer P; Nock V
Pharm Res; 2021 Oct; 38(10):1645-1661. PubMed ID: 34664206
[TBL] [Abstract][Full Text] [Related]
17. Physiologically based pharmacokinetic modeling to predict maternal pharmacokinetics and fetal carbamazepine exposure during pregnancy.
Chen Y; Ke M; Fang W; Jiang Y; Lin R; Wu W; Huang P; Lin C
Eur J Pharm Sci; 2024 Mar; 194():106707. PubMed ID: 38244810
[TBL] [Abstract][Full Text] [Related]
18. Development of Physiologically Based Organ Models to Evaluate the Pharmacokinetics of Drugs in the Testes and the Thyroid Gland.
Pilari S; Gaub T; Block M; Görlitz L
CPT Pharmacometrics Syst Pharmacol; 2017 Aug; 6(8):532-542. PubMed ID: 28571120
[TBL] [Abstract][Full Text] [Related]
19. The development of a pregnancy PBPK Model for Bisphenol A and its evaluation with the available biomonitoring data.
Sharma RP; Schuhmacher M; Kumar V
Sci Total Environ; 2018 May; 624():55-68. PubMed ID: 29247905
[TBL] [Abstract][Full Text] [Related]
20. Clinical Pharmacokinetic Studies in Pregnant Women and the Relevance of Pharmacometric Tools.
Dallmann A; Mian P; Van den Anker J; Allegaert K
Curr Pharm Des; 2019; 25(5):483-495. PubMed ID: 30894099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
